Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
R&D
Trials
Page 2
Trials
Erenumab to prevent migraine: results from phase III STRIBE
staff
-
14 December 2017
0
Positive results of phase 2 trial on nivolumab/ipilimumab Combo in SCLC
staff
-
18 October 2017
0
Negative topline results of intepirdine phase 3 MINDSET trial in Alzheimer’s Disease
staff
-
18 October 2017
0
Alzheimer’s disease: trigriluzole phase 2 trial in collaboration with ADCS
staff
-
18 October 2017
0
NBTXR3 will be tested in combination with immune checkpoints inhibitors
staff
-
18 October 2017
0
Good results for a phase I/II head and neck cancer trial
staff
-
14 June 2017
0
Results of the antibiotic cadazolid
staff
-
13 June 2017
0
Chinese cell therapy effective in small multiple myeloma trial
staff
-
13 June 2017
0
Omecamtiv mecarbil Phase 2 results in chronic heart failure
Cristiana Bernini
-
19 December 2016
0
Alirocumab ODYSSEY trial on alirocumab will continue as planned following interim analysis
Cristiana Bernini
-
19 December 2016
0
1
2
3
...
6
Page 2 of 6
